Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, Brooks Hill Partners is a venture capital firm based in Waltham, Massachusetts, specializing in life sciences and early-stage health tech. The firm manages a portfolio of 12 companies and partners with clients ranging from startups to large corporations.
Brooks Hill Partners invests in life sciences and health tech companies at various stages, including pre-seed, seed, and growth equity. They provide critical support during development and pre-commercial phases, emphasizing customized solutions that leverage data-driven strategies to enhance organizational capabilities.
Notable portfolio companies include 3Derm, a skin imaging system; Astrocyte Pharmaceuticals, focused on brain injury treatment; and Calibrater Health, which develops intelligent process automation software for healthcare. Other companies include DEEP 6 AI, Macula, and ProCredEx.
Email info@brookshillpartners.com with your deck to pitch them directly.
Yes, Brooks Hill Partners often leads investment rounds, particularly in their focus sectors of life sciences and health tech.
The firm is open to follow-on investments, especially for portfolio companies that demonstrate significant growth potential and alignment with their investment thesis.
Specific fund size details are not publicly disclosed, but the firm actively manages a portfolio of 12 companies across various stages of development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.